Politician trade (House)

Baxter International (BAX): Rep. Lisa C. McClain (MI09) disclosed a purchase $1K–$15K

Rep. Lisa C. McClain (MI09) disclosed a purchase of Baxter International in the $1K–$15K range.

$1,001–$15,000
Reported range · official band, not an exact amount
27 days
Disclosure lag
Traded
Sep 25, 2025
Disclosed
Oct 22, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jul 22, 2025CongressDisclosed purchase of BAX — reported range $1,001 - $15,000
  2. Aug 4, 2025CongressDisclosed sale of BAX — reported range $1,001 - $15,000
  3. Aug 29, 2025FDARecall: CLEARLINK System Solution Set, DUO-VENT, CLEARLINK Luer Activated Valve, 10 drops/mL, 92-inch (2.3 meters), Product code 2C8419
  4. Aug 29, 2025FDARecall: CLEARLINK SYSTEM CONTINU-FLO Solution Set, Non-Vented, 0.2 Micron Filter, two CLEARLINK Luer Activated Valves, Backcheck Valve, 10 drops/mL, 104-inch (2.6 mete…
  5. Aug 29, 2025FDARecall: CLEARLINK SYSTEM CONTINU-FLO Solution Set, Non-Vented, three CLEARLINK Luer Activated Valves, Backcheck Valve, Retractable Collar, 10 drops/mL, 120-inch (3.0 m…
  6. Aug 29, 2025FDARecall: CLEARLINK SYSTEM EXTENSION SET, Straight-Type Extension Set, Standard Bore, CLEARLINK Luer Activated Valve, Retractable Collar, 14-inch (35 centimeters), Produ…
  7. Aug 29, 2025FDARecall: CLEARLINK SYSTEM CONTINU-FLO Solution Set, Non-Vented, three CLEARLINK Luer Activated Valves, Backcheck Valve, Retractable Collar, 10 drops/mL, 120-inch (3.0 m…
  8. Aug 29, 2025FDARecall: CLEARLINK SYSTEM CONTINU-FLO Solution Set, Non-Vented, three CLEARLINK Luer Activated Valves, Backcheck Valve, 10 drops/mL, 120-inch (3.0 meters), Non-DEHP, Pr…
  9. Aug 29, 2025FDARecall: CLEARLINK SYSTEM NON-DEHP CONTINU-FLO SOLN SET, 96" (2,4 m), Product Code: 2H8519
  10. Sep 2, 20255% stakePZENA INVESTMENT MANAGEMENT LLC reported a passive stake (13G) of 10.8%
  11. Sep 17, 2025FDAFDA drug approval: Ketamine Hydrochloride
  12. Sep 17, 2025FDARecall: Oral Probe (Product code 02893-000), accessory used with Welch Allyn SureTemp Plus 690 (Product codes 01690-200 and 01690-400) Thermometers and Welch Allyn Sur…
  13. Sep 25, 2025 · this disclosureCongressDisclosed purchase of BAX — reported range $1,001 - $15,000

What came next

  1. Oct 16, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On October 16, 2025, Heather Knight notified Baxter International Inc. (the “Company”) of her decision to resign as the Company’s Executive Vice President, Chief Operating Officer (“COO”) and interim group president of Medical Products and Therapies (“MPT”), effective as of October 29, 2025 (the “Transition Date”), to join a company in the healthcare industry.”
  2. Oct 16, 2025Court · District Court, N.D. IllinoisSecurities lawsuit filed: Electrical Workers Pension Fund, Local 103 IBEW v. Baxter International, Inc.
  3. Oct 17, 20255% stakeBlackRock Portfolio Management LLC reported a passive stake (13G) of 7.6%
  4. Oct 28, 2025FDARecall: Welch Allyn INF BAG, Thigh 1-Tube, Model/Catalog Number: REF 5089-18; Product replacement bladder for the Welch Allyn Two-Piece Blood Pressure Cuff.
  5. Oct 30, 2025Company filing · Form 8-K · ResultsReported its results
  6. Oct 30, 2025Congress · 1 personMembers of Congress: 1 purchase, 1 sale
  7. Oct 31, 2025CongressDisclosed sale of BAX — reported range $1,001 - $15,000
  8. Nov 5, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On November 5, 2025, Alok Sonig notified Baxter International Inc. (the “Company”) of his decision to resign as the Company’s Executive Vice President and Group President, Pharmaceuticals, effective as of December 1, 2025, to join a company in the healthcare industry.”
  9. Nov 13, 20255% stakeDodge & Cox reported a passive stake (13G) of 11.2%
  10. Nov 24, 2025Government · Federal Register ruleMedicare Program; End-Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals With Acute Kidney Injury, End-Stage Renal Disease Quality Incentive Program, and End-Stage Renal Disease Treatment Choices Model
  11. Nov 25, 2025Company filing · Form 8-K · Material agreementSigned an important agreement
  12. Nov 28, 2025FDARecall: SIGMA Spectrum Infusion Pump, Model/Catalog Number: 35700BAX2
  13. Dec 3, 2025Court · District Court, N.D. IllinoisSecurities lawsuit filed: City of Hallandale Beach Police Officers' and Firefighters' Personnel Retirement Trust v. Baxter International, Inc.
  14. Dec 4, 2025Company filing · Form 8-K · Material agreement, Agreement endedSigned an important agreement, and ended an important agreement (and 2 more items)
  15. Dec 16, 2025FDAFDA device clearance: Welch Allyn FlexiPort Blood Pressure Cuffs (FlexiPort Blood Pressure Cuffs)
  16. Dec 22, 2025FDARecall: Sterile Water for Irrigation, 250 mL, Single-Dose Plastic Bottle, Rx Only, Baxter Healthcare Corporation Deerfield, IL 60015 NDC: 0338-0004-02.
  17. Jan 13, 2026FDARecall: Brand Name: Spectrum IQ Product Name: Infusion Pump Model/Catalog Number: 3570009 Software Version: N/A Product Description: Infusion Pump, one unit per carton…
  18. Jan 16, 2026FDAFDA device clearance: WAVE Clinical Platform (2.0.000)
  19. Jan 21, 20265% stakePZENA INVESTMENT MANAGEMENT LLC reported a passive stake (13G) of 13.8%
  20. Jan 21, 20265% stakeBlackRock Portfolio Management LLC reported a passive stake (13G) of 8.7%
View the official recordHouse Clerk periodic transaction report

How to read House Clerk periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Baxter International

For Baxter International, OQRO holds 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BAX page.

Other recent filings by Rep. Lisa C. McClain (MI09)

The full history of Rep. Lisa C. McClain (MI09) is on the profile page.

How this filing works

Explore the data

Common questions

Which member of Congress traded Baxter International (BAX) stock, and how much?

Rep. Lisa C. McClain (MI09) disclosed a purchase of Baxter International in the $1K–$15K range. Reported range, not an exact amount, Spouse account.

When did it happen, and when was it made public?

Traded: Sep 25, 2025. Disclosed: Oct 22, 2025. That is 27 days between the two dates.

Why is the amount a range and not an exact figure?

Members of Congress report each trade in a bracket set by law ($1,001 to $15,000, $15,001 to $50,000, and so on), never an exact amount. OQRO keeps the bracket as filed and does not estimate a figure inside it.

Where does this information come from?

From the House Clerk periodic transaction report, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Baxter International recently?

For Baxter International, OQRO holds 1 fund holdings report (13F) dated in the last 90 days. They are listed on the BAX page.

Does this mean BAX stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Baxter International

Everything OQRO holds on this company is on its BAX page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data